Auteur S. HUTCHINSON

  Tris disponibles Ajouter le résultat à votre sélection

  Affiner la recherche

Effectiveness of needle/syringe programmes and opiate substitution therapy in preventing HCV transmission among people who inject drugs [Protocol]

L. PLATT ; J. REED ; S. MINOZZI ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; M. HICKMAN | 2016
Dans Cochrane Database of Systematic Reviews (n°1, 2016) Article : Périodique

This is the protocol for a review and there is no abstract. The objectives are as follows: 1. To assess the impact of needle/syringe programmes with and without opiate substitution therapy (OST) on the incidence of HCV infection among people w[...]

Plus d'info

Ajouter à la sélection

Lien externe

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews

N. E. PALMATEER ; J. KIMBER ; M. HICKMAN ; S. HUTCHINSON ; T. RHODES ; D. GOLDBERG | 2010
Dans Addiction (Vol.105, n°5, May 2010) Article : Périodique

AIMS: To review the evidence on the effectiveness of harm reduction interventions involving the provision of sterile injecting equipment in the prevention of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) transmission among injec[...]

Plus d'info

Ajouter à la sélection

High risk injecting behaviour among injectors from Glasgow: cross sectional community wide surveys 1990-1999

A. TAYLOR ; D. GOLDBERG ; S. HUTCHINSON ; S. CAMERON ; R. FOX | 2001
Dans Journal of Epidemiology and Community Health (Vol.55, n°10, October 2001) Article : Périodique

In 1988, the UK Departments of Health gave approval for sterile needles and syringes to be made available to injecting drug users, thus obviating their need to inject with used equipment.1 Since then, several hundred needle/syringe exchange sche[...]

Plus d'info

Ajouter à la sélection

Lien externe

Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings - what is required to achieve the WHO's HCV elimination targets?

Z. WARD ; L. PLATT ; S. SWEENEY ; V. D. HOPE ; L. MAHER ; S. HUTCHINSON ; N. PALMATEER ; J. SMITH ; N. CRAINE ; A. TAYLOR ; N. MARTIN ; R. AYRES ; J. DILLON ; M. HICKMAN ; P. VICKERMAN | 2018
Dans Addiction (Vol.113, n°9, September 2018) Article : Périodique

Aims: To estimate the impact of existing high-coverage needle and syringe provision (HCNSP, defined as obtaining more than one sterile needle and syringe per injection reported) and opioid substitution therapy (OST) on hepatitis C virus (HCV) tr[...]

Plus d'info

Ajouter à la sélection

Interventions to prevent HIV and Hepatitis C among people who inject drugs: Latest evidence of effectiveness from a systematic review (2011 to 2020)

N. PALMATEER ; V. HAMILL ; A. BERGENSTROM ; H. BLOOMFIELD ; L. GORDON ; J. STONE ; H. FRASER ; T. SEYLER ; Y. DUAN ; R. TRAN ; K. TRAYNER ; C. BIGGAM ; S. SMITH ; P. VICKERMAN ; M. HICKMAN ; S. HUTCHINSON | 2022
Dans International Journal of Drug Policy (Vol.109, November 2022) Article : Périodique

Background: Hepatitis C virus (HCV) and HIV remain prevalent among people who inject drugs (PWID) and transmission is usually associated with injecting risk behaviour (IRB). We update a 2011 review of reviews (RoR) to assess the latest evidence [...]

Plus d'info

Ajouter à la sélection

Lien externe

Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe

H. FRASER ; N. K. MARTIN ; H. BRUMMER-KORVENKONTIO ; P. CARRIERI ; O. DALGARD ; J. DILLON ; D. GOLDBERG ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. A. MATSER ; M. MATICIC ; H. MIDGARD ; V. MRAVCIK ; A. OVREHUS ; M. PRINS ; J. REIMER ; G. ROBAEYS ; B. SCHULTE ; D. K. VAN SANTEN ; R. ZIMMERMANN ; P. VICKERMAN ; M. HICKMAN | 2018
Dans Journal of Hepatology (Vol.68, n°3, March 2018) Article : Périodique

BACKGROUND & AIMS: Prevention of hepatitis C virus (HCV) transmission among people who inject drugs (PWID) is critical for eliminating HCV in Europe. We estimated the impact of current and scaled-up HCV treatment with and without scaling up opio[...]

Plus d'info

Ajouter à la sélection

Lien externe

Nouveauté

Mortality and cause of death in a cohort of people who had ever injected drugs in Glasgow: 1982-2012

D. NAMBIAR ; A. WEIR ; E. J. ASPINALL ; M. STOOVE ; S. HUTCHINSON ; P. DIETZE ; L. WAUGH ; D. J. GOLDBERG | 2015
Dans Drug and Alcohol Dependence (Vol.147, February 2015) Article : Périodique

Background: To describe all-cause and cause-specific mortality in a cohort of people who had ever injected drugs (PWID) with a low prevalence of HIV over 20-30 years. Methods: Using a retrospective study design, identifying data from a cohort o[...]

Plus d'info

Ajouter à la sélection

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis

L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN | 2018
Dans Addiction (Vol.113, n°3, March 2018) Article : Périodique

Aims: To estimate the effects of needle and syringe programmes (NSP) and opioid substitution therapy (OST), alone or in combination, for preventing acquisition of hepatitis C virus (HCV) in people who inject drugs (PWID). Methods: Systematic re[...]

Plus d'info

Ajouter à la sélection

Lien externe

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs [Intervention review]

L. PLATT ; S. MINOZZI ; J. REED ; P. VICKERMAN ; H. HAGAN ; C. FRENCH ; A. JORDAN ; L. DEGENHARDT ; V. HOPE ; S. HUTCHINSON ; L. MAHER ; N. PALMATEER ; A. TAYLOR ; J. BRUNEAU ; M. HICKMAN | 2017
Dans Cochrane Database of Systematic Reviews (n°9, 2017) Article : Périodique

Review question: We examine research on the effect of needle syringe programmes (NSP) and opioid substitution treatment (OST) in reducing the risk of becoming infected with the hepatitis C virus. Background: There are around 114.9 million peopl[...]

Plus d'info

Ajouter à la sélection

Lien externe

Severe illness and death among injecting drug users in Scotland: a case-control study

A. TAYLOR ; S. HUTCHINSON ; LINGAPPA J. ; S. WADD ; S. AHMED ; L. GRUER ; T. H. Jr TAYLOR ; K. ROY ; G. GILCHRIST ; MCGUIGAN C. ; PENRICE G. ; D. GOLDBERG | 2004
Périodique

ENGLISH : Between April and September 2000, 60 injecting drug users in Scotland died or were hospitalized with severe illness. Laboratory investigations suggested that Clostridium novyi and other bacteria were important aetiological agents. To[...]

Plus d'info

Ajouter à la sélection

Standardising monitoring data on drug-related infectious diseases among people who inject drugs in Europe - an update of the European Union Drugs Agency technical protocol, 2024

I. SPERLE ; T. SEYLER ; F. PERICOLI ; E. DUFFELL ; S. HUTCHINSON ; M. JAUFFRET-ROUSTIDE ; M. KABERG ; A. KIVITE-URTANE ; C. SEGUIN-DEVAUX ; V. SYPSA ; R. ZIMMERMANN | 2025
Dans Eurosurveillance (Vol.30, n°30, 31 July 2025) Article : Périodique

Drug-related infectious diseases (DRID), such as HIV, hepatitis B virus (HBV) and hepatitis C virus (HCV), contribute to high morbidity and mortality among people who inject drugs (PWID). The European Union Drugs Agency (EUDA) is responsible for[...]

Plus d'info

Ajouter à la sélection

Lien externe

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

K. M. E. TURNER ; S. HUTCHINSON ; P. VICKERMAN ; V. HOPE ; N. CRAINE ; N. E. PALMATEER ; M. MAY ; A. TAYLOR ; D. DE ANGELIS ; S. CAMERON ; J. PARRY ; M. LYONS ; D. GOLDBERG ; E. ALLEN ; M. HICKMAN | 2011
Dans Addiction (Vol.106, n°11, November 2011) Article : Périodique

AIMS To investigate whether opiate substitution therapy (OST) and needle and syringe programmes (NSP) can reduce hepatitis C virus (HCV) transmission among injecting drug users (IDUs). DESIGN Meta-analysis and pooled analysis, with logistic re[...]

Plus d'info

Ajouter à la sélection

Lien externe

Trends in HCV prevalence among injecting drug users in Glasgow and Edinburgh during the era of needle/syringe exchange

D. GOLDBERG ; S. BURNS ; A. TAYLOR ; S. CAMERON ; HARGREAVES D. ; S. HUTCHINSON | 2001
Périodique

ENGLISH : In 1998, we reported that anti-HCV prevalence among injectors from Glasgow had declined between 1990 and 1995. We set out to ascertain if the anti-HCV prevalence among injectors from Edinburgh had declined similarly during this perio[...]

Plus d'info

Ajouter à la sélection